Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonists.

MLA

Bambi-Nyanguile, Sylvie-Mireille, et al. “Synthesis and Pharmacological Evaluation of 2-Aryloxy/Arylamino-5-Cyanobenzenesulfonylureas as Novel Thromboxane A₂ Receptor Antagonists.” European Journal of Medicinal Chemistry, vol. 65, July 2013, pp. 32–40. EBSCOhost, https://doi.org/10.1016/j.ejmech.2013.04.033.

APA

Bambi-Nyanguile, S.-M., Hanson, J., Ooms, A., Alpan, L., Kolh, P., Dogné, J.-M., & Pirotte, B. (2013). Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A₂ receptor antagonists. European Journal of Medicinal Chemistry, 65, 32–40. https://doi.org/10.1016/j.ejmech.2013.04.033

Chicago

Bambi-Nyanguile, Sylvie-Mireille, Julien Hanson, Annie Ooms, Lutfiye Alpan, Philippe Kolh, Jean-Michel Dogné, and Bernard Pirotte. 2013. “Synthesis and Pharmacological Evaluation of 2-Aryloxy/Arylamino-5-Cyanobenzenesulfonylureas as Novel Thromboxane A₂ Receptor Antagonists.” European Journal of Medicinal Chemistry 65 (July): 32–40. doi:10.1016/j.ejmech.2013.04.033.